Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Audioboom and American Lung Association. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audioboom and American Lung Association or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Lungcast: Current Perspectives on Treatment of Small Cell Lung Cancer with Jacob Sands, MD

36:20
 
Share
 

Manage episode 502939110 series 3310605
Content provided by Audioboom and American Lung Association. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audioboom and American Lung Association or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
While major advances in screening, targeted treatment and immunotherapy have transformed outcomes for non-small cell lung cancer, progress against small cell lung cancer (SCLC) has lagged behind. In this episode, Jacob Sands, MD, of Dana-Farber Cancer Institute and Harvard Medical School joins us to share insights into the present state of SCLC treatment, from staging and standard therapies to new research on vaccines that could one day change the course of this aggressive disease.
  continue reading

66 episodes

Artwork
iconShare
 
Manage episode 502939110 series 3310605
Content provided by Audioboom and American Lung Association. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audioboom and American Lung Association or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
While major advances in screening, targeted treatment and immunotherapy have transformed outcomes for non-small cell lung cancer, progress against small cell lung cancer (SCLC) has lagged behind. In this episode, Jacob Sands, MD, of Dana-Farber Cancer Institute and Harvard Medical School joins us to share insights into the present state of SCLC treatment, from staging and standard therapies to new research on vaccines that could one day change the course of this aggressive disease.
  continue reading

66 episodes

ทุกตอน

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play